Start Date
November 30, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
epoetin alfa
Group 1 will receive Procrit once every three weeks, and group 2 will receive Procrit every week.
Collaborators (1)
Ortho Biotech Clinical Affairs, L.L.C.
INDUSTRY
PPD Development, LP
INDUSTRY
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Washington University School of Medicine
OTHER